We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.49B
AUM Growth
-$96.8M
(-1.1%)
Cap. Flow
-$229M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
17.82%
Holding
2,013
New
45
Increased
399
Reduced
1,471
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$32.4M |
| 2 |
Amgen
AMGN
|
+$13.1M |
| 3 |
Medtronic
MDT
|
+$8.19M |
| 4 |
CELG
Celgene Corp
CELG
|
+$8.07M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$36.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$14.1M |
| 3 |
Microsoft
MSFT
|
+$10.4M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$9.41M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.97% |
| 3 | Financials | 14.32% |
| 4 | Communication Services | 7.87% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
RH
RH
$3.3B
| $624K | 0.01% |
6,294
-686
| -10% | -$62.3K |
|
|
ABMD
1077
DELISTED
Abiomed Inc
ABMD
| $623K | 0.01% |
8,708
-812
| -9% | -$44.1K |
|
|
GRA
1078
DELISTED
W.R. Grace & Co.
GRA
| $623K | 0.01% |
6,306
-1,384
| -18% | -$132K |
|
|
PRA
1079
DELISTED
ProAssurance
PRA
| $622K | 0.01% |
13,542
+1,568
| +13% | +$71.3K |
|
|
SCMP
1080
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $615K | 0.01% |
39,539
+6,360
| +19% | +$98.6K |
|
|
INVX
1081
Innovex International
INVX
$1.87B
| $612K | 0.01% |
8,955
-351
| -4% | -$25.3K |
|
|
BRSL
1082
Brightstar Lottery PLC
BRSL
$1.91B
| $611K | 0.01% |
35,107
-5,871
| -14% | -$102K |
|
1083
Euronet Worldwide
EEFT
$3.02B
| $609K | 0.01% |
10,366
-1,021
| -9% | -$54.1K |
|
1084
Travere Therapeutics
TVTX
$5.33B
| $609K | 0.01% |
25,429
+3,177
| +14% | +$48.4K |
|
1085
Eagle Materials
EXP
$6.6B
| $608K | 0.01% |
7,279
-1,147
| -14% | -$89.3K |
|
|
BRS
1086
DELISTED
Bristow Group, Inc.
BRS
| $608K | 0.01% |
11,166
+71
| +0.6% | +$4.2K |
|
1087
Copart
CPRT
$25.9B
| $607K | 0.01% |
129,184
-22,432
| -15% | -$104K |
|
|
ISIL
1088
DELISTED
Intersil Corp
ISIL
| $607K | 0.01% |
42,414
-4,912
| -10% | -$72.9K |
|
|
ALE
1089
DELISTED
Allete
ALE
| $605K | 0.01% |
11,459
-836
| -7% | -$45.9K |
|
1090
Popular Inc
BPOP
$11B
| $605K | 0.01% |
17,604
-1,394
| -7% | -$46.1K |
|
1091
Kirby Corp
KEX
$7.95B
| $605K | 0.01% |
8,065
-1,503
| -16% | -$116K |
|
|
LPNT
1092
DELISTED
LifePoint Health, Inc.
LPNT
| $605K | 0.01% |
8,234
-1,223
| -13% | -$86.8K |
|
|
SLCA
1093
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $604K | 0.01% |
16,968
-106
| -0.6% | -$3.1K |
|
|
KATE
1094
DELISTED
Kate Spade & Company
KATE
| $601K | 0.01% |
18,012
-3,117
| -15% | -$98.7K |
|
|
AOL
1095
DELISTED
AOL INC COMMON STOCK
AOL
| $601K | 0.01% |
15,172
-3,355
| -18% | -$144K |
|
1096
Lexicon Pharmaceuticals
LXRX
$1.02B
| $597K | 0.01% |
90,289
+33,908
| +60% | +$232K |
|
1097
TD Synnex
SNX
$19.4B
| $596K | 0.01% |
15,432
-2,396
| -13% | -$92.1K |
|
|
VR
1098
DELISTED
Validus Hold Ltd
VR
| $596K | 0.01% |
14,164
-2,549
| -15% | -$105K |
|
|
EQY
1099
DELISTED
Equity One
EQY
| $595K | 0.01% |
22,278
-2,641
| -11% | -$71K |
|
1100
Flowers Foods
FLO
$1.64B
| $592K | 0.01% |
26,049
-4,628
| -15% | -$96.1K |
|
Similar funds
ProShare Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, ProShare Advisors held 2,013 positions worth $8.49B, down 1.1% from $8.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors's Q1 2015 filing shows 45 new, 399 increased, 1,471 reduced and 95 closed positions. Its largest new stake was Qorvo: 60,564 shares worth $4.83M. The largest sale was Visa, an estimated $36.5M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- ProShare Advisors's largest Q1 2015 buy was Qorvo: 60,564 shares worth $4.83M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q1 2015, an estimated $32.4M increase.
- ProShare Advisors's biggest Q1 2015 reduction was Visa, cutting an estimated $36.5M.
- ProShare Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $14.1M.
- ProShare Advisors's ten largest holdings make up 18% of its $8.49B portfolio in Q1 2015.
- ProShare Advisors opened 45 new positions and closed 95 in Q1 2015.
- ProShare Advisors's portfolio value fell 1.1% quarter-over-quarter to $8.49B.
Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.